tasty live announces free live trading events for 2025
CHICAGO--(BUSINESS WIRE)--tasty live, the world's largest digital financial network for active derivatives traders, is hitting the road with a high-energy series of live trading events across the U.S. and Europe — and you're invited. Whether you're a seasoned trader or just curious about the markets, these free, in-person events are designed to educate, entertain, and connect.
Whether you're a seasoned trader or just curious about the markets, these free, in-person events are designed to educate, entertain, and connect.
Share
Known for streaming bold, no-fluff financial content 24/7, tasty live is powered by industry legend Tom Sosnoff, founder of both thinkorswim and tasty live. For more than a decade, the tasty live team has crisscrossed the U.S. and UK, hosting unforgettable events that bring trading insights to life. Now, for the first time ever, tasty live is headed to Milan, Italy, adding a little "dolce vita" to the mix.
Space is limited and RSVPs are required. Don't miss your chance to experience tasty live live — with real talk, real trades, and maybe a few surprises.
Get all the details and save your seat at: https://www.tastylive.com/events
'Tom & Tony: At Work by 11am'
Beginning in May 2025, legendary options trader Tom Sosnoff and his trusty sidekick Tony 'Bat' Battista, will hit the road together for their first live trading events – ever! The events are a live trading experience like no other: fun, challenging, silly, and fast-paced, offering not only the chance to watch the legends do their thing in-person, but also the opportunity to connect with other like-minded individuals and share stories, tips, and strategies, with light refreshments, fun swag, and a meet-and-greet with Tom (nobody wants to meet Tony). Did we mention the event is free?
'Tom & Tony: At Work by 11am'
Date
Location
May 30, 2025
Atlanta, GA
June 20, 2025
London, UK
June 23, 2025
Milan, Italy
July 25, 2025
Denver, CO
August 15, 2025
Chicago, IL
September 5, 2025
San Francisco, CA
September 19, 2025
New York City, NY
October 3, 2025
Los Angeles, CA
October 24, 2025
Charlotte, NC
November 7, 2025
Austin, TX
Expand
'The 2025 Whiteboard Tour: Featuring Nick, Katie, and Mike'
The next generation of tasty live talent takes over. Please join Nick Battista, Katie McGarrigle, and Mike Butler as they cover complex option strategies, crypto, and portfolio mechanics in a non-stop, 90-minute show. These free evening events are being held in smaller, intimate locations with time allocated for Q&A.
'The 2025 Whiteboard Tour: Featuring Nick, Katie, and Mike'
Date
Location
June 12, 2025
Washington, DC
August 10, 2025
Seattle, WA
October 12, 2025
Dallas, TX
November 2, 2025
San Diego, CA
Expand
'Options Crash Course Live! Featuring tasty live 's Dr. Jim'
Join Dr. Jim Schultz as he covers an introduction to strategic finance in a free, non-stop, intimate, 90-minute show.
'Options Crash Course Live! Featuring tasty live 's Dr. Jim'
Date
Location
Boston, MA
October 19, 2025
Detroit, MI
December 7, 2025
Tampa, FL
Expand
Click here to view video and here to view photos of previous shows.
Click here to be the first to receive updates about tasty live events.
About tasty live
tasty live is focused on empowering investors through its award-winning financial content and media network. Established in 2011 to reinvent the accessibility of quantitative options and futures content and education for individual investors, tasty live offers 12 hours of daily, live, free programming 5 days a week to self-directed investors in 190 countries.
tasty live is part of IG US Holdings, Inc., parent to online retail brokerage tastytrade, tasty Software Solutions, LLC, tastyfx, LLC, and a subsidiary of IG Group Holdings plc (LON:IGG), a global fintech company that provides award-winning products, platforms and access to ~19,000 financial markets to investors around the world. Learn more at www.tastylive.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
34 minutes ago
- Business Wire
Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease
LA JOLLA, Calif.--(BUSINESS WIRE)-- Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatric diseases, today announced the publication of preclinical data in Nature Communications demonstrating that its lead drug candidate, ART5803, effectively blocks the underlying disease mechanism in anti-NMDA receptor encephalitis (ANRE) and rapidly reverses behavioral symptoms in a non-human primate model. The findings support the continued clinical development of ART5803 as a first-in-class, targeted therapeutic. The company is currently completing Phase 1 safety studies for ART5803 and plans Phase 2 evaluation in anti-NMDA receptor encephalitis (ANRE) and autoimmune psychosis patients in the second half of 2025. 'This study underscores the promise of ART5803 to directly address neuropsychiatric disease caused by anti-NMDA receptor-targeting pathogenic antibodies,' said Peter Flynn, Ph.D. President and CEO of Arialys Therapeutics. Share 'This study underscores the promise of ART5803 to directly address neuropsychiatric disease caused by anti-NMDA receptor-targeting pathogenic antibodies,' said Peter Flynn, Ph.D. President and CEO of Arialys Therapeutics. 'Despite our understanding of the disease mechanism and its severity, ANRE lacks an approved therapy. Further, there is a growing body of data identifying significant levels of anti-NMDA receptor autoantibodies in subpopulations of patients diagnosed with diseases that result in psychosis and dementia.' 'These data provide compelling evidence that ART5803 can directly block the pathogenic effect of autoantibodies that target the NMDA receptor, resulting in a rapid resolution of symptoms,' said Mitsuyuki (Mickey) Matsumoto, Ph.D., Chief Scientific Officer of Arialys Therapeutics and senior author of the paper. 'Our detailed structural and functional analyses confirm that ART5803 precisely inhibits NMDA receptor internalization induced by the pathogenic autoantibodies, while preserving normal receptor function. In addition, our discovery of a potential molecular mimicry mechanism for anti-NMDA receptor autoantibody generation broadens the understanding of disease initiation and may inform future indication expansion for ART5803.' Anti-NMDA receptor encephalitis (ANRE) is a rare, potentially lethal, poorly managed, and often misdiagnosed neurological disease. ANRE is caused by pathogenic autoantibodies that bind to and crosslink NMDA receptors in the brain, leading to receptor internalization and synaptic dysfunction. The result is a range of debilitating neuropsychiatric symptoms including psychiatric and behavioral alterations, cognitive decline, seizures, coma, and diminished autonomic function. A significant percentage of ANRE patients are pediatric, where NMDA receptor-specific autoantibodies can also result in neurological development deficits. There are no approved therapies for this disease, and current treatments rely on broadly immunosuppressive therapies, which are associated with delayed efficacy and significant side effects. Recent findings have also identified anti-NMDA receptor autoantibodies in other neurological and psychiatric diseases such as schizophrenia, depression, bipolar disorder, and dementia. Arialys is planning clinical assessment of ART5803 in anti-NMDA receptor autoantibody-positive psychosis patients. The company is also currently testing patient samples using a proprietary high-throughput screen for autoantibodies to identify enriched disease indications and subpopulations for future clinical development. ART5803 is a humanized, monovalent IgG1 antibody engineered to selectively bind the GluN1 subunit of the NMDA receptor without disrupting receptor function or causing internalization. In this study, ART5803 demonstrated the ability to potently block NMDA receptor internalization in cellular and neuronal models and reversed both molecular and behavioral hallmarks of disease in a novel marmoset model of ANRE. Notably, ART5803 exhibited rapid onset of action and was well tolerated in vivo. The publication also includes a detailed characterization of ART5803's binding epitope, its mechanism of action, and population pharmacokinetic modeling supporting the feasibility of systemic administration in patients. In addition to demonstrating the therapeutic potential of ART5803, the paper revealed a potential link between infections—specifically Toxoplasma gondii and certain bacterial pathogens—and the generation of pathogenic anti-NMDA receptor autoantibodies. Epitope mapping analysis identified regions of potential molecular mimicry between microbial proteins and the GluN1 subunit of the NMDA receptor, suggesting that infections could serve as environmental triggers for disease initiation. Notably, toxoplasmosis and bacterial infections are well-established risk factors for a range of neuropsychiatric conditions. These findings not only suggest a basis for disease pathogenesis but also support broader therapeutic opportunities for ART5803 across autoimmune neuropsychiatric disorders. ART5803 is currently being evaluated in a Phase 1 clinical trial in healthy volunteers. In February 2025, Arialys announced completion of all single ascending dose (SAD) cohorts and initiation of multiple ascending dose (MAD) cohorts. The company expects to share initial clinical data in the second half of 2025 and initiate Phase 2 proof-of-concept studies. The publication was completed in collaboration with researchers from Astellas Pharma Inc., University of California, Davis, Kitasato University School of Medicine, and Vanadro LLC. About Arialys Therapeutics Arialys was founded by investors Avalon Bioventures, Catalys Pacific and MPM to meaningfully expand the treatment possibilities for neuropsychiatric disorders driven by autoimmune disease. Using a combination of highly sensitive autoantibody detection, patient sampling and receptor structural biology, Arialys has developed a first-in-class precision therapy to specifically block pathogenic autoantibodies in the brain. Arialys is headquartered in La Jolla, California. For more information, visit
Business Wire
34 minutes ago
- Business Wire
AXL Launches Venture Studio with $15M to Build 50 AI Companies, Fuelling Canada's Global Leadership in AI Research-to-Commercialization
TORONTO--(BUSINESS WIRE)--Today, AXL, a new Canadian venture studio transforming world-class AI research into high-growth companies, has launched with a plan to build 50 AI-powered companies over the next five years to fuel Canada's research-to-commercialization pipeline. This is enabled by an oversubscribed first closing of its venture fund of $15 million CAD. With this, AXL will form and scale homegrown innovation — and keep it here. Daniel Wigdor, one of Canada's top innovators and AXL's Co-Founder and CEO, is reinvesting back into the Canadian tech ecosystem as the fund's lead investor, following the sale of his previous company, Chatham Labs, to Meta, where he served as the founding director of their Toronto research centre. AXL is also backed by a coalition of successful Canadian entities and strategic industry investors rallying around the future of AI in Canada, including David Martin, Founder of Smart Technologies; Gord Kurtenbach, former Head of Autodesk Research; Joshua Greer, Founder of Real-D; Frank Mersch, Chief Investment Officer and Senior Portfolio Manager of Front Street Capital; Rob McEwen, Chairman and Chief Owner of McEwen Mining; and many of Canada's leading professors in applied AI. As the global AI race heats up, Canada faces mounting pressure to retain its intellectual property and top talent to secure its leadership. Over the past decade, American firms have acquired 70 Canadian AI companies and counting, while Silicon Valley firms have opened large local offices, resulting in the loss of valuable intellectual property and potential upside. According to a study by Element AI in 2018, Canada experienced a net talent outflow, underscoring the challenge of retaining its top AI minds. 'Canada has a long history of pioneering breakthroughs, including AI, yet we've repeatedly failed to capture the value of our own innovations as our talent and biggest ideas scale somewhere else,' said Daniel Wigdor, Co-Founder and CEO of AXL. 'We're here to change that by connecting Canada's AI excellence with real market needs and the full-stack support that founders need to win globally.' Where research becomes scalable ventures Founded by a team of seasoned tech entrepreneurs and executives — Daniel Wigdor, Tovi Grossman, David Sharma, and Ray Sharma — AXL combines decades of experience scaling companies worldwide in a mission to bridge cutting-edge research with commercial success. AXL's proprietary venture studio model integrates access to AI research from the University of Toronto with market insights from Canada's top businesses through its AI Catalyst program. In this corporate partnership initiative, leading Canadian companies like Dillon Consulting partner with AXL to investigate how AI could reshape their businesses, often becoming the first customer and strategic investor in resulting ventures. This blend creates an environment where ventures are rooted in validated industry demand, supported by a full-stack team that manages everything from prototype and application development to legal, finance, sales, and growth strategies. 'Our corporate partnerships are the engine that transforms lab breakthroughs into ventures with real-world traction,' said David Sharma, Chief Growth Officer at AXL. 'By collaborating directly with Canada's private sector, we ensure that innovation is guided by genuine industry needs and positioned for rapid adoption. This approach closes a critical gap in Canada's innovation system, turning bright ideas into scalable solutions that deliver long-term value for our partners and the broader economy.' Seeing beyond the horizon NVIDIA's Jensen Huang has called Canada the 'Epicentre of Modern AI,' but what's lesser known is Canada's leadership in applied computing, the field that converts foundational research into practical tools. Applied computing bridges the gap between advanced technology and everyday life, making advanced technology more accessible to all. 'The transformative power of AI will come from impactful, practical applications, not just large models or infrastructure,' said Wigdor. 'Focusing solely on building bigger models risks missing the real opportunities in creating tools that genuinely empower people and open new possibilities in our daily lives.' Canada's 'AI moment' is here. It's a once-in-a-generation opportunity to fundamentally shift the balance of power in the tech industry. While the rest of the world rushes to commoditize infrastructure, AXL can see past that horizon by investing in the application layer, well beyond what Silicon Valley is currently betting on. 'If we do this right, we won't be saying things like 'Toronto is the Silicon Valley of Ontario.' Two decades from now, San Francisco will be trying to brand itself the 'Toronto of California,'' added Wigdor. Canada's path to a self-sustaining, world-leading AI ecosystem AXL is committed to nurturing a new generation of founders by providing capital, mentorship, operations, and the infrastructure necessary to turn ideas into impactful ventures, with the broader mission of creating a thriving, self-sustaining AI ecosystem that retains talent, intellectual property, and economic prosperity within Canada. 'We believe that Canadian entrepreneurs deserve the opportunity to build and scale world-class AI-powered companies here at home,' added Wigdor. 'With AXL, we're creating the infrastructure and community needed to transform innovation into lasting impact.' To learn more about how AXL is fuelling Canada's AI research to commercialization pipeline, visit their website at ABOUT AXL AXL is a Canadian venture studio transforming world-class research into high-growth companies that shape the future of applied AI. Led by seasoned tech entrepreneurs and applied AI experts, AXL's mission is to ensure Canada's top breakthroughs are built and scaled at home. By connecting academia with real market demand and full-stack venture creation, AXL helps Canada move from invention to impact, anchoring talent, intellectual property, and long-term economic value within the country.
Business Wire
an hour ago
- Business Wire
NFC Forum Announces NFC Release 15
LONDON--(BUSINESS WIRE)-- NFC Forum, the global standards body for Near Field Communication (NFC) technology, has announced NFC Release 15, supporting the latest advancements in NFC Forum-certified technologies. NFC Release 15 will extend the range of certified compliant NFC contactless connections up to 2cm – 4x greater than the current range of 0.5cm, supporting faster, more reliable contactless interactions across a growing number of use cases such as wireless charging, kitchen appliances, wearables, and digital keys. This innovation means that connections will start sooner and require less precise device alignment, making NFC quicker, more reliable, and easier to use than ever. Led by its Board members, including representatives from Apple, Google, Huawei, Identiv, Infineon, NXP, Sony, and ST Microelectronics, NFC Forum empowers organizations to deliver seamless, secure contactless interactions to users around the globe, with conformance to the Forum's specifications helping to ensure intuitive, reliable and consistent experiences. NFC Release 15 will extend the range – also known as the operating volume – of NFC contactless interactions. This innovation means that connections will start sooner and require less precise device alignment, making NFC quicker, more reliable and easier to use than ever. Contactless connections will be more seamless, while retaining the critical need for user intent. 'Extending the range of NFC contactless connections was one of the key priorities outlined in the NFC Forum Five-Year Roadmap, to meet changing market needs and deliver faster, easier transactions across all NFC enabled devices – including smaller form factors such as wearables or smartphones,' comments Mike McCamon, Executive Director of NFC Forum. 'Many markets are set to benefit from extended range, with consumers set to gain the most through an enhanced user experience. Redefining the baseline for contactless connections, NFC Release 15 is also expected to advance new and exciting use cases, such as using your mobile phone as a payment terminal, as well as optimize NFC usability across a variety of sectors, including automotive, transit and access control.' NFC Release 15 also marks the latest step in NFC Forum's ongoing commitment to sustainability, as one of its other core focuses is support for the NFC Digital Product Passport Standard. The standard gives brand and product teams a flexible, data agnostic framework to allow a single NFC tag embedded in a product to store and transmit both standard and extended DPP data using common NFC Data Exchange Format (NDEF) records. NFC Release 15 will therefore help to ensure reliability, interoperability, and compatibility across all NFC devices used for the DPP, throughout a product's entire lifecycle. 'NFC technology makes our lives more convenient, secure and connected every single day. NFC Release 15 will continue to extend contactless simplicity into an ever-expanding list of use cases – including sustainability – and redefine the baseline for performance standards,' continues McCamon. 'NFC Forum is committed to helping organizations deliver secure, reliable and convenient proximity-based connections, driven by user intent. Through NFC Release 15, we are proud to enable these NFC interactions as the technology, its applications and ability to drive a more connected, sustainable future show no signs of slowing.' NFC Forum Associate, Principal, and Sponsor-level member companies can download the Technical Specifications included in NFC Release 15 today. Adopter-level members and the public can access and begin certifying compliance to NFC Release 15 from Fall 2025. To learn more about NFC Release 15 and how it will enable extended range, the circular economy and expansion of use cases, register to attend our upcoming webinar on Wednesday 9 th July. About the NFC Forum The NFC Forum, established in 2004, is a non-profit industry association comprised of leading mobile communications, semiconductor, and consumer electronics companies. Its mission is to advance the use of Near Field Communication technology by developing specifications, ensuring interoperability, and educating the market about NFC technology. The NFC Forum's global member companies share skills, technical expertise and industry knowledge to develop specifications and protocols for interoperable data exchange, device-independent service delivery, and device capability. Forum's supporting certification program and user marks enhance and promote a consistent, reliable, seamless and secure NFC user experience. To learn more about joining the Forum, visit Follow the NFC Forum on LinkedIn and YouTube.
